Literature DB >> 25267016

Adipocyte cell size, free fatty acids and apolipoproteins are associated with non-alcoholic liver injury progression in severely obese patients.

Alexander Wree1, Martin Schlattjan2, Lars P Bechmann2, Thierry Claudel3, Jan-Peter Sowa2, Tatjana Stojakovic4, Hubert Scharnagl4, Harald Köfeler5, Hideo A Baba6, Guido Gerken2, Ariel E Feldstein7, Michael Trauner8, Ali Canbay9.   

Abstract

PURPOSE: Obesity is a modern pandemic with continuous expansion and represents an independent risk factor for non-alcoholic fatty liver disease (NAFLD), the most common liver disease in westernized countries. The crosstalk between adipose tissue and the liver is key to the development of NAFLD. PROCEDURES: Therefore, in an observational study blood, visceral adipose tissue and liver tissue were obtained from 93 severely obese patients with a mean age of 43 years and mean BMI of 52 kg/m2 at the time of weight loss surgery. In a subset of patients a follow-up blood sample was obtained 6 weeks after surgery to assess acute effects of weight loss. In addition to routine parameters of liver injury, serum samples were analyzed for leptin, adiponectin, free fatty acids (FFAs), and several apolipoproteins. MAIN
FINDINGS: The diameter of visceral adipocytes correlated to liver injury, serum markers of inflammation and serum adipokine levels. Liver injury assessed by serology (ALT, AST) and histology (NAFLD activity score, NAS) was independent of the BMI. However, serum levels of triglycerides and Apolipoprotein CIII (ApoCIII) were associated with NAS. Serum levels and composition of FFAs, especially long chain FFAs, also correlated with NAS. Analysis of serum samples six weeks after surgery revealed beneficial changes in serum triglycerides, levels of ApoCIII and several FFAs.
CONCLUSIONS: In severely obese patients beneficial effects on liver injury can been observed as early as six weeks after bariatric surgery. These effects may be explained by the observed changes in adipose tissue and lipid metabolism. Collectively, these findings underline the importance of the link between adipose tissue and the liver.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adipose tissue; Bariatric surgery; Hepatology; Non-alcoholic fatty liver disease; Obesity

Mesh:

Substances:

Year:  2014        PMID: 25267016     DOI: 10.1016/j.metabol.2014.09.001

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  38 in total

1.  Homeostatic balance of histone acetylation and deconstruction of repressive chromatin marker H3K9me3 during adipocyte differentiation of 3T3-L1 cells.

Authors:  Han-Heom Na; Keun-Cheol Kim
Journal:  Genes Genomics       Date:  2018-08-09       Impact factor: 1.839

2.  Effects of Bariatric Surgery on Non-alcoholic Fatty Liver Disease: Magnetic Resonance Imaging Is an Effective, Non-invasive Method to Evaluate Changes in the Liver Fat Fraction.

Authors:  Dennis M Hedderich; Till Hasenberg; Stefan Haneder; Stefan O Schoenberg; Özlem Kücükoglu; Ali Canbay; Mirko Otto
Journal:  Obes Surg       Date:  2017-07       Impact factor: 4.129

3.  What Is the Role of the New Index Relative Fat Mass (RFM) in the Assessment of Nonalcoholic Fatty Liver Disease (NAFLD)?

Authors:  Mariana V Machado; Sara Policarpo; J Coutinho; Sofia Carvalhana; Jorge Leitão; Armando Carvalho; Ana P Silva; Francisco Velasco; Isabel Medeiros; Ana Catarina Alves; Mafalda Bourbon; Helena Cortez-Pinto
Journal:  Obes Surg       Date:  2020-02       Impact factor: 4.129

4.  Fattening chips: hypertrophy, feeding, and fasting of human white adipocytes in vitro.

Authors:  Benjamin D Pope; Curtis R Warren; Madeleine O Dahl; Christina V Pizza; Douglas E Henze; Nina R Sinatra; Grant M Gonzalez; Huibin Chang; Qihan Liu; Aaron L Glieberman; John P Ferrier; Chad A Cowan; Kevin Kit Parker
Journal:  Lab Chip       Date:  2020-11-10       Impact factor: 6.799

5.  Chronic angiotensin AT2R activation prevents high-fat diet-induced adiposity and obesity in female mice independent of estrogen.

Authors:  Sourashish Nag; Mohammad Azhar Khan; Preethi Samuel; Quaisar Ali; Tahir Hussain
Journal:  Metabolism       Date:  2015-03-14       Impact factor: 8.694

6.  Associations of insulin resistance, inflammation and liver synthetic function with very low-density lipoprotein: The Cardiovascular Health Study.

Authors:  Z Gordon Jiang; Ian H de Boer; Rachel H Mackey; Majken K Jensen; Michelle Lai; Simon C Robson; Russell Tracy; Lewis H Kuller; Kenneth J Mukamal
Journal:  Metabolism       Date:  2015-10-22       Impact factor: 8.694

Review 7.  NASH Cirrhosis - the New Burden in Liver Transplantation: How Should It Be Managed?

Authors:  Ali Canbay; Jan-Peter Sowa; Wing-Kin Syn; Jürgen Treckmann
Journal:  Visc Med       Date:  2016-07-29

8.  Diet-Induced Nonalcoholic Fatty Liver Disease Is Associated with Sarcopenia and Decreased Serum Insulin-Like Growth Factor-1.

Authors:  Daniel Cabrera; Alex Ruiz; Claudio Cabello-Verrugio; Enrique Brandan; Lisbell Estrada; Margarita Pizarro; Nancy Solis; Javiera Torres; Francisco Barrera; Marco Arrese
Journal:  Dig Dis Sci       Date:  2016-08-29       Impact factor: 3.199

Review 9.  Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Authors:  Gregory Thomas Brown; David E Kleiner
Journal:  Metabolism       Date:  2015-12-02       Impact factor: 8.694

Review 10.  Microenvironmental Control of Adipocyte Fate and Function.

Authors:  Benjamin D Pope; Curtis R Warren; Kevin Kit Parker; Chad A Cowan
Journal:  Trends Cell Biol       Date:  2016-06-04       Impact factor: 20.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.